- Home
- AMBO vs ADIL Comparison
AMBO vs ADIL Comparison
Compare AMBO & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBO
- ADIL
- Stock Information
- Founded
- AMBO 2000
- ADIL 2010
- Country
- AMBO United States
- ADIL United States
- Employees
- AMBO N/A
- ADIL N/A
- Industry
- AMBO Other Consumer Services
- ADIL Biotechnology: Pharmaceutical Preparations
- Sector
- AMBO Real Estate
- ADIL Health Care
- Exchange
- AMBO Nasdaq
- ADIL Nasdaq
- Market Cap
- AMBO 8.3M
- ADIL 7.6M
- IPO Year
- AMBO 2010
- ADIL 2018
- Fundamental
- Price
- AMBO $2.90
- ADIL $0.46
- Analyst Decision
- AMBO
- ADIL Strong Buy
- Analyst Count
- AMBO 0
- ADIL 1
- Target Price
- AMBO N/A
- ADIL $8.00
- AVG Volume (30 Days)
- AMBO 14.0K
- ADIL 4.5M
- Earning Date
- AMBO 01-01-0001
- ADIL 08-12-2025
- Dividend Yield
- AMBO N/A
- ADIL N/A
- EPS Growth
- AMBO N/A
- ADIL N/A
- EPS
- AMBO 0.11
- ADIL N/A
- Revenue
- AMBO $9,392,000.00
- ADIL N/A
- Revenue This Year
- AMBO N/A
- ADIL N/A
- Revenue Next Year
- AMBO N/A
- ADIL N/A
- P/E Ratio
- AMBO $26.39
- ADIL N/A
- Revenue Growth
- AMBO 2.50
- ADIL N/A
- 52 Week Low
- AMBO $1.00
- ADIL $0.22
- 52 Week High
- AMBO $5.55
- ADIL $1.30
- Technical
- Relative Strength Index (RSI)
- AMBO 55.26
- ADIL 49.79
- Support Level
- AMBO $2.53
- ADIL $0.45
- Resistance Level
- AMBO $3.00
- ADIL $0.76
- Average True Range (ATR)
- AMBO 0.26
- ADIL 0.08
- MACD
- AMBO 0.01
- ADIL 0.01
- Stochastic Oscillator
- AMBO 68.45
- ADIL 25.63
About AMBO Ambow Education Holding Ltd.
Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.